Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT00794040Phase 2Completed
A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation
Attention Deficit and Disruptive Behavior DisorderAttention Deficit Hyperactivity DisorderMental Disorder Diagnosed in Childhood+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Robert McNamara, PhD

University of Cincinnati

Related
7 trials

Shared therapeutic areas:

Attention Deficit Disorder with HyperactivityMood Disorders

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score15%

Carlos A Zarate, M.D.

National Institute of Mental Health (NIMH)

Related
19 trials

Shared therapeutic areas:

Mood DisordersAttention Deficit Disorder with Hyperactivity

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score15%

Daniel S Pine, M.D.

National Institute of Mental Health (NIMH)

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score8%

Ru-Lan Hsieh, MD

Shin Kong Wu Ho-Su Memorial Hospital

Related
13 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Janet Wozniak, MD

Massachusetts General Hospital

Related
11 trials

Shared therapeutic areas:

Mood Disorders
Similarity Score8%

Sabine Wilhelm, PhD

Massachusetts General Hospital

Related
9 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Theresa Winhusen, Ph.D.

University of Cincinnati

Related
6 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Karen Sepucha, PhD

Massachusetts General Hospital

Related
10 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Roger deBeus, PhD

Skyland Behavioral Health Associates

Related
2 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Nobuhito Sanada

Otsuka Pharmaceutical Co., Ltd.

Related
11 trials

Shared therapeutic areas:

Attention Deficit Disorder with Hyperactivity
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT00794040Phase 2PrincipalInvestigator

A Controlled Trial of Serotonin Reuptake Inhibitors Added to Stimulant Medication in Youth With Severe Mood Dysregulation

Attention Deficit and Disruptive Behavior DisorderAttention Deficit Hyperactivity DisorderMental Disorder Diagnosed in Childhood+1 more
Completed

All 1 trials loaded